Abstract:Background: Centrosomal protein 55 (CEP55) is implicated in the tumorigenesis of bladder cancer (BC) but the detailed molecular mechanisms are unknown. We aim to develop a potential competing endogenous RNA (ceRNA) network related with CEP55 in BC. Methods: We first extracted the expression profiles of RNAs from The Cancer Genome Atlas (TCGA) database and used bioinformatic analysis to establish ceRNAs in BC. Real-time quantity PCR (RT-qPCR) and immunohistochemical analysis were performed to measure CEP55 expression in different bladder cell lines and different grades of cancer. Bioinformatics analysis and luciferase assays were conducted to predict potential binding sites among miR-497-5p, CEP55, parathyroid hormone like hormone (PTHLH) and high mobility group A2 (HMGA2). Tumor xenograft model was used to show the effect of CEP55 3'-UTR on cisplatin therapy. Bioinformatics analysis, luciferase assays, and 5' rapid amplification of cDNA ends (5'RACE) were to explore the function of CEP55 3'-untranslated region (3'-UTR) on targeting miR-497-5p. Western blot and immunofluorescence assays were to detect the epithelial-mesenchymal transition (EMT) induction of CEP55 3'-UTR. Results: CEP55 expression as well as the expression levels of the oncogenic proteins PTHLH and HMGA2 were upregulated in BC cells while miR-497-5p was downregulated. Low miR-497-5p expression and high CEP55 and HMGA2 expression levels were associated with more advanced tumor clinical stage and pathological grade. Overexpression of the CEP55 3'-UTR promoted the proliferation, migration, and invasion of the EJ cell line in vitro and accelerated EJ-derived tumor growth in nude mice, while inhibition of the CEP55 3'-UTR suppressed all of these oncogenic processes. In addition, CEP55 3'-UTR upregulation reduced the cisplatin sensitivity of BC cell lines and xenograft tumors. Bioinformatics analysis, luciferase assays, and 5'RACE suggested that the CEP55 3'-UTR functions as a ceRNA targeting miR-497-5p, leading to miR-497-5p downregulation and disinhibition of PTHLH and HMGA2 expression. Further, CEP55 downregulated miR-497-5p transcription by promoting NF-[Formula: see text]B signaling. In turn, CEP55 3'-UTR ultimately promotes EMT and tumorigenesis by activating P38MAPK and ERK 1/2 pathways. Conclusions: These results suggest that a ceRNA regulatory network involving CEP55 upregulates PTHLH and HMGA2 expression by suppressing endogenous miR-497-5p. We unveiled a novel mechanism of BC metastasis, and could become novel therapeutics targets in BC.

C/EBPβ Promotes the Viability of Human Bladder Cancer Cell by Contributing to the Transcription of Bladder Cancer Specific Lncrna UCA1.

Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis.

UCA1, a Non‐protein‐coding RNA Up‐regulated in Bladder Carcinoma and Embryo, Influencing Cell Growth and Promoting Invasion

Ets-2 Regulates Cell Apoptosis Via The Akt Pathway, Through The Regulation Of Urothelial Cancer Associated 1, A Long Non-Coding Rna, In Bladder Cancer Cells

Increased Expression of Long Non-Coding RNA CCEPR is Associated with Poor Prognosis and Promotes Tumorigenesis in Urothelial Bladder Carcinoma

Long Non-Coding RNA UCA1 Regulated Cell Cycle Distribution Via CREB Through PI3-K Dependent Pathway in Bladder Carcinoma Cells.

Long Non-Coding RNA Urothelial Carcinoma Associated 1 Induces Cell Replication by Inhibiting BRG1 in 5637 Cells

Long Non-Coding RNA UCA1a(CUDR) Promotes Proliferation and Tumorigenesis of Bladder Cancer.

Mechanistic study of NUPR1 in bladder cancer development through transcriptional regulation of CCR2

Differential Expression Profile Analysis Of Lncrna Uca1 Alpha Regulated Mrnas In Bladder Cancer

Differential expression profile analysis of lncRNA UCA1α regulated mRNAs in bladder cancer.

The common region of lncRNAs <i>UCA1</i> and <i>UCA1</i> contributes to the bladder cancer tumorigenesis

Urothelial Carcinoma Associated 1 is a Hypoxia-Inducible Factor-1Α-targeted Long Noncoding RNA That Enhances Hypoxic Bladder Cancer Cell Proliferation, Migration, and Invasion

LncRNA UCA1 Promotes the Invasion and EMT of Bladder Cancer Cells by Regulating the Mir-143/Hmgb1 Pathway.

Long noncoding RNA UCA1 inhibits epirubicin-induced apoptosis by activating PPARα-mediated lipid metabolism

UCA1, Its Variant Transcripts and Bladder Cancer

Hypoxia Regulates the Expression and Localization of CCAAT/enhancer Binding Protein Α by Hypoxia Inducible Factor-1Α in Bladder Transitional Carcinoma Cells

LncRNA UCA1 Maintains the Low-Tumorigenic and Nonmetastatic Status by Stabilizing E-cadherin in Primary Prostate Cancer Cells.

CEP55 3'-UTR promotes epithelial-mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR-497-5p

Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma

Upregulation of C/EBPα Contributes to Colorectal Cancer Growth, Metastasis and Indicates Poor Survival Outcome.